Rhinovirus respiratory infections and asthma (Q34602661)

3 August 2017

1 reference

title

Rhinovirus respiratory infections and asthma (English)

1 reference

3 August 2017

0 references

James E Gern

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

American Journal of Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

112 Suppl 6A

1 reference

3 August 2017

page(s)

19S-27S

1 reference

Rhinovirus infections in an industrial population. I. The occurrence of illness

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Respiratory viruses and exacerbations of asthma in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Virus-induced airway hyperresponsiveness and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Detection of rhinovirus RNA in lower airway cells during experimentally induced infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Rhinoviruses infect the lower airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Thermal mapping of the airways in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Rhinovirus replication causes RANTES production in primary bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Analysis of nasal secretions during experimental rhinovirus upper respiratory infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

The treatment of rhinovirus infections: progress and potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Oral prednisone therapy in experimental rhinovirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

Differences between asthma exacerbations and poor asthma control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901060-9

10.1016/S0002-9343(01)01060-9

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference